Literature DB >> 28391785

Radiologically Isolated Syndrome: MR Imaging Features Suggestive of Multiple Sclerosis Prior to First Symptom Onset.

Darin T Okuda1.   

Abstract

Remarkable advances in the understanding of the biology of multiple sclerosis have been achieved through the use of conventional and novel MR imaging techniques of the central nervous system. With improvements in access by patients and utilization of MR imaging technology in health care, an increasing number of unanticipated structural anomalies are being appreciated. In certain instances, white matter abnormalities within the brain and spinal cord are discovered in subjects with no prior history of neurologic symptoms supportive of inflammatory demyelinating events.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MR imaging; Multiple sclerosis; Radiologically isolated syndrome

Mesh:

Year:  2017        PMID: 28391785     DOI: 10.1016/j.nic.2016.12.008

Source DB:  PubMed          Journal:  Neuroimaging Clin N Am        ISSN: 1052-5149            Impact factor:   2.264


  3 in total

1.  Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States.

Authors:  Ahmed Z Obeidat; Yasir N Jassam; Le H Hua; Gary Cutter; Corey C Ford; June Halper; Robert P Lisak; Nancy L Sicotte; Erin E Longbrake
Journal:  Neurology       Date:  2020-02-27       Impact factor: 11.800

2.  Rituximab, MS, and pregnancy.

Authors:  Jessica B Smith; Kerstin Hellwig; Katharina Fink; Deirdre J Lyell; Fredrik Piehl; Annette Langer-Gould
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-05-01

3.  Onset Symptom Clusters in Multiple Sclerosis: Characteristics, Comorbidities, and Risk Factors.

Authors:  Vladeta Ajdacic-Gross; Nina Steinemann; Gábor Horváth; Stephanie Rodgers; Marco Kaufmann; Yanhua Xu; Christian P Kamm; Jürg Kesselring; Zina-Mary Manjaly; Chiara Zecca; Pasquale Calabrese; Milo A Puhan; Viktor von Wyl
Journal:  Front Neurol       Date:  2021-07-06       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.